Skip to content
Clinical Trials – home

Respiratory failure Diagnostics

2 / 3 trials open to patients3 countries

In short

Getting the right diagnosis for respiratory failure can make the difference between life and death. Understanding when to seek medical help, what tests doctors use to identify the problem, and how these tests work is crucial for anyone facing breathing difficulties or caring for someone who is.

Key points

  • A simple finger clip test called pulse oximetry can provide crucial early warning of respiratory problems by measuring oxygen levels in seconds.
  • The gold standard arterial blood gas test measures three critical values—oxygen, carbon dioxide, and pH—that together tell doctors exactly what type of respiratory failure you have and how urgent treatment needs to be.
  • A bluish tint to your skin, lips, or fingernails is not just cosmetic—it is a visible sign that your blood oxygen is dangerously low and requires immediate medical attention.
  • Respiratory failure comes in different types, and accurate diagnosis helps doctors choose the right treatment—too little oxygen requires one approach while too much carbon dioxide requires another.
  • Your blood's pH level acts like a clock, revealing whether respiratory failure developed over hours or weeks, which dramatically affects treatment strategy and prognosis.
  • Clinical trials for respiratory failure treatments require very specific diagnostic criteria, including precise blood gas cutoff values and documented lung abnormalities on imaging.
  • Confusion or extreme sleepiness in someone with breathing problems is not just a symptom—it is a diagnostic clue that their brain is being affected by abnormal oxygen or carbon dioxide levels.
  • The same diagnostic tests can serve two purposes: identifying respiratory failure in an emergency and monitoring chronic conditions to prevent life-threatening complications before they occur.

Introduction: When to Seek Diagnostic Testing

Respiratory failure is a serious medical condition that requires prompt attention. You should seek diagnostic evaluation immediately if you or someone you care for experiences sudden trouble breathing, confusion, a bluish color on the skin or lips, or an inability to speak due to breathlessness. These are warning signs that your body may not be getting enough oxygen or may have too much carbon dioxide building up in your blood.

People who already have lung conditions like chronic obstructive pulmonary disease (COPD), asthma, or cystic fibrosis should be especially watchful. If your symptoms suddenly worsen, if you feel more short of breath than usual, or if you notice increased confusion or extreme tiredness, these changes may signal that your condition is progressing toward respiratory failure. Even if you have been managing your condition at home, a sudden change means it is time to get medical help.

It is also important to understand that respiratory failure does not always announce itself dramatically. In some cases, especially with chronic respiratory failure, symptoms develop slowly over days or weeks. You might notice that everyday activities like walking or cooking become harder, that you feel tired all the time, or that you cannot sleep well because of breathing problems. If you have any of these ongoing symptoms, you should talk to your healthcare provider about getting tested.

Certain groups of people should be more vigilant about seeking diagnostic testing. Those who smoke or have smoked in the past, older adults, people with heart disease, those who have had a stroke or spinal cord injury, and anyone taking opioid medications or sedatives are at higher risk. If you fall into any of these categories and notice changes in your breathing, it is wise to get checked sooner rather than later.

Classic Diagnostic Methods

Initial Assessment and Physical Examination

When you arrive at a hospital or clinic with breathing problems, the medical team will begin with a rapid assessment of your condition. They will check how fast you are breathing, whether you are using extra muscles in your neck and chest to help you breathe, and whether your breathing sounds normal. A doctor or nurse will listen to your lungs with a stethoscope to detect any abnormal sounds like wheezing or crackling. They will also listen to your heart to check for irregular rhythms, which can occur when your organs are not getting enough oxygen.

During the physical exam, the healthcare provider will look carefully at your skin, lips, and fingernails. A bluish color, called cyanosis, is a sign that your blood does not have enough oxygen. They will also check whether you are confused or very sleepy, which can happen when carbon dioxide builds up to dangerous levels or when your brain is not getting enough oxygen. Your mental state is actually an important indicator of how severe your respiratory failure might be.

The medical team will ask about your medical history, including whether you have any lung diseases, heart problems, or other conditions that might affect your breathing. They will want to know if you have recently had an infection, been exposed to smoke or harmful fumes, taken any medications, or suffered any injuries. All of this information helps them understand what might be causing your respiratory problems and guides them toward the right diagnostic tests.

Blood Oxygen Measurement

One of the first and most important tests you will receive is pulse oximetry. This is a simple, painless test that uses a small sensor, usually clipped onto the end of your finger or attached to your ear. The sensor shines a light through your skin and measures how much oxygen is in your blood. The result is displayed as a percentage, and doctors use this number to quickly assess whether your blood has enough oxygen. Normal oxygen levels are typically above 95 percent, but levels below 90 percent are concerning and often require immediate treatment.

While pulse oximetry is very useful for a quick check, it does not tell the whole story. It measures the oxygen in your blood but does not measure carbon dioxide levels, which are equally important in respiratory failure. That is why doctors often need to perform a more detailed test called an arterial blood gas test.

Arterial Blood Gas Testing

An arterial blood gas test is the gold standard for diagnosing respiratory failure. This test measures the exact levels of oxygen and carbon dioxide in your blood, as well as your blood's pH level, which tells doctors how acidic or alkaline your blood is. To perform this test, a healthcare provider takes a blood sample from an artery, usually in your wrist. This is different from most blood tests, which take blood from a vein.

The results of the arterial blood gas test help doctors classify the type of respiratory failure you have. If your oxygen level is too low (below 60 millimeters of mercury, or mmHg), this indicates hypoxemic respiratory failure, also known as Type 1 respiratory failure. If your carbon dioxide level is too high (above 45 or 50 mmHg), this indicates hypercapnic respiratory failure, or Type 2 respiratory failure. Sometimes people have both problems at once.

The pH measurement helps doctors understand how quickly the respiratory failure developed. If the pH is very low (below 7.3), it suggests the condition came on suddenly, meaning it is acute respiratory failure. If the pH is closer to normal, it may mean the respiratory failure developed over a longer time, allowing your body to partially compensate. This distinction is important because acute respiratory failure requires more urgent, aggressive treatment.

Chest Imaging

A chest X-ray is usually one of the first imaging tests doctors will order when respiratory failure is suspected. This test creates a picture of your lungs, heart, and chest cavity using a small amount of radiation. It can show whether there is fluid in your lungs, whether parts of your lungs have collapsed, whether you have pneumonia or other infections, or whether your heart is enlarged. All of these findings help identify what is causing your breathing problems.

In more complex cases, doctors may order a computed tomography scan, or CT scan. A CT scan provides much more detailed images than a regular X-ray. It can show smaller abnormalities, help detect blood clots in the lungs (called pulmonary embolism), and give a clearer picture of lung damage or disease. The CT scan machine takes many X-ray pictures from different angles and uses a computer to combine them into detailed cross-sectional images of your chest.

Heart Function Tests

Because the heart and lungs work closely together, problems with your heart can cause or contribute to respiratory failure. That is why doctors often perform an electrocardiogram, or EKG. This is a simple test that records your heart's electrical activity by placing small electrodes on your chest, arms, and legs. The test can detect irregular heart rhythms, signs of a heart attack, or evidence that your heart is under strain from low oxygen levels or lung disease.

In some cases, doctors may also use echocardiography, which is an ultrasound of the heart. This test uses sound waves to create moving pictures of your heart. It shows how well your heart is pumping blood and whether there are any structural problems. Echocardiography can also detect increased pressure in the blood vessels of your lungs, a condition called pulmonary hypertension, which sometimes accompanies chronic respiratory failure.

Monitoring Carbon Dioxide Levels

In addition to blood tests, doctors can monitor carbon dioxide levels in your breath using a device called a capnometer or capnograph. This non-invasive method measures the amount of carbon dioxide you exhale with each breath. A capnograph not only gives a number but also creates a waveform that shows how carbon dioxide levels change during the breathing cycle. This can provide real-time information about how well your lungs are removing carbon dioxide and can help guide treatment decisions, especially if you are on a breathing machine.

Additional Laboratory Tests

Depending on what doctors suspect is causing your respiratory failure, they may order other blood tests. A complete blood count can show if you have an infection or anemia. Tests of your kidney and liver function help determine if other organs are being affected. If doctors think you might have a blood clot in your lungs, they may order a test called a D-dimer, which measures a substance released when blood clots break down.

Diagnostics for Clinical Trial Qualification

When patients with respiratory failure are being considered for enrollment in clinical trials, they typically undergo a standard set of diagnostic tests to ensure they meet the study criteria. Clinical trials are research studies that test new treatments, and they require very specific information about each participant's condition to ensure the results are accurate and meaningful.

The definition of respiratory failure used in clinical trials usually includes three main criteria: an increased rate of breathing (faster than normal), abnormal blood gas measurements showing low oxygen or high carbon dioxide or both, and clear evidence that the person is working harder to breathe than normal. All of these must be documented through objective testing before a patient can be enrolled in most studies.

Arterial blood gas measurements are essential for clinical trial qualification. Trials often have very specific cutoff values for oxygen and carbon dioxide levels. For instance, a study might only include patients whose oxygen level in arterial blood is below a certain number, such as 60 mmHg, or whose carbon dioxide level is above 50 mmHg. These strict criteria help researchers study a specific type or severity of respiratory failure.

Chest X-rays are also commonly required as part of the screening process for clinical trials. Researchers need to document what the lungs look like before treatment begins so they can track any changes during the study. Some trials specifically focus on conditions that show particular patterns on chest imaging, such as acute respiratory distress syndrome (ARDS), which shows fluid in both lungs on an X-ray or CT scan.

Pulmonary function tests may be required for some clinical trials, especially those studying chronic respiratory conditions. These tests measure how much air your lungs can hold, how quickly you can move air in and out of your lungs, and how well oxygen passes from your lungs into your blood. However, these tests are often not practical in acute respiratory failure because patients are too sick to perform them properly.

Clinical trials may also require documentation of the underlying cause of respiratory failure. For example, if a trial is testing a treatment for ARDS caused by pneumonia, researchers will need proof that you have both ARDS and pneumonia through imaging studies, blood tests, or tests of fluid from your lungs. This ensures that all participants in the study have similar conditions, which makes the results more reliable.

Some research studies also track additional measurements such as the ratio between your oxygen level and the amount of oxygen you are receiving through supplemental oxygen or a breathing machine. This ratio, often abbreviated as PaO2/FiO2, helps researchers classify the severity of respiratory failure and monitor whether treatments are working. A lower ratio indicates more severe lung dysfunction.

Regular monitoring throughout a clinical trial is just as important as the initial diagnostic tests. Participants typically have their blood gases, oxygen levels, and chest imaging repeated at specific time points during the study. This ongoing testing helps researchers determine whether the experimental treatment is safe and effective. It also allows doctors to quickly identify if a participant's condition is worsening and needs different treatment.

Prognosis and Survival Rate

Prognosis

The outlook for people with respiratory failure varies widely depending on many factors. The underlying cause plays a major role in determining prognosis. People whose respiratory failure is caused by a treatable condition, such as a drug overdose or a lung infection that responds to antibiotics, often recover completely once the underlying problem is addressed. On the other hand, respiratory failure caused by severe, progressive diseases like advanced COPD or pulmonary fibrosis may have a less favorable outlook.

How quickly respiratory failure develops also affects the prognosis. Acute respiratory failure that comes on suddenly is immediately life-threatening and requires emergency treatment, but if treated promptly and effectively, many people can recover. Chronic respiratory failure that develops slowly over time may allow for better adaptation and management, though it often indicates more advanced underlying disease.

The severity of abnormalities in blood gases and pH levels influences outcomes. Very low oxygen levels or very high carbon dioxide levels, especially when combined with severe acidosis (low pH), indicate more critical illness and carry higher risks. The presence of complications such as organ damage to the heart, brain, kidneys, or other organs also worsens the prognosis.

Age and overall health status are important predictive factors. Older adults and those with multiple medical conditions tend to have more difficult recoveries and higher risks of complications. Conversely, younger people without other health problems who develop respiratory failure from a reversible cause often have better outcomes. Physical fitness level and nutritional status before developing respiratory failure can also influence recovery.

For chronic respiratory failure, the outlook depends heavily on how well the underlying condition can be managed. People who quit smoking, follow their treatment plans, use oxygen therapy as prescribed, and participate in pulmonary rehabilitation programs generally have better long-term outcomes than those who do not. Ongoing medical care and monitoring are essential for managing chronic respiratory failure and preventing sudden worsening that could lead to hospitalization or death.

Survival rate

The incidence of respiratory failure varies considerably depending on the definition used and the population studied. Research indicates that respiratory failure occurs at a rate of approximately 10 to 80 cases per 100,000 people, reflecting the wide range of conditions that can cause this syndrome.

It is important to understand that respiratory failure itself is not a single disease but rather a consequence of many different conditions. Because of this, overall survival statistics can be misleading, as outcomes vary dramatically based on the underlying cause. For instance, respiratory failure caused by asthma has a much better prognosis than respiratory failure caused by end-stage lung cancer or severe ARDS.

The course of COPD-related respiratory failure, one of the most common causes of chronic respiratory failure, is particularly difficult to predict because the disease progresses at different rates in different people. Life expectancy for people with COPD-related respiratory failure depends on factors including smoking history, fitness level, nutritional status, and the degree of breathlessness experienced. Many people with COPD develop chronic respiratory failure that can be managed for years with appropriate treatment.

Acute respiratory distress syndrome (ARDS), a severe form of acute respiratory failure, historically has had high mortality rates. However, advances in treatment, including improved mechanical ventilation strategies, have led to better survival in recent years. The severity of ARDS, the underlying cause, and the presence of other organ failures all influence survival chances.

Recovery from respiratory failure, especially when mechanical ventilation is required, can be a long process. Some people may experience ongoing symptoms such as shortness of breath, fatigue, and reduced exercise capacity for weeks or even months after the acute episode. Long-term complications can include weakness, post-traumatic stress, and in some cases, permanent lung damage. Following up with healthcare providers and participating in rehabilitation programs can help improve long-term outcomes.

Did you know?

  1. Your body's pH level can reveal how fast respiratory failure developed—a pH below 7.3 indicates the condition came on suddenly, while a near-normal pH suggests it developed slowly enough for your body to partially compensate.
  2. Pulse oximetry, the simple clip-on-your-finger test, was only invented in the 1970s, yet it has become so essential to medicine that it is now often called the "fifth vital sign" alongside temperature, pulse, blood pressure, and breathing rate.
  3. The typical reference values doctors use for diagnosing respiratory failure—oxygen pressure above 80 mmHg and carbon dioxide below 45 mmHg—are specifically for people at sea level; these numbers change at higher altitudes where there is naturally less oxygen in the air.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Respiratory failure

Recruiting trials first

See all 3 trials →
Quick filters

3 clinical trials in this condition

Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Enoxaparin Sodium
  • Sponsor:Medical University Of Vienna
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Iloprost Trometamol
  • Sponsor:Rigshospitalet
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Methylprednisolone
  • Sponsor:Assistance Publique Hopitaux De Paris
See all 3 trials →filters applied: condition = Respiratory failure

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).